This inventor holds 5 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Josef Straub: Innovator in Cancer Treatment
Introduction
Josef Straub is a notable inventor based in Seeheim-Jugenheim, Germany. He has made significant contributions to the field of cancer treatment, particularly through his innovative patents. With a total of 5 patents, his work focuses on advanced therapeutic methods for colorectal cancer and bone metastasis diseases.
Latest Patents
One of his latest patents is for Abituzumab, an anti-alpha-v integrin antibody designed for the treatment of colorectal cancer. This method includes administering Abituzumab to patients suffering from Stage II-IV colorectal cancer, metastatic colorectal cancer, and left-sided colorectal cancer. The patent emphasizes the potential of Abituzumab in combination with targeted therapy concepts and chemotherapy. Another significant patent involves a method for treating bone metastasis diseases, which relies on specific protein levels in body fluids to predict treatment outcomes. This innovative approach includes the use of pan αv integrin inhibitors to enhance treatment efficacy.
Career Highlights
Throughout his career, Josef Straub has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and MDxHealth, SA. His experience in these organizations has contributed to his expertise in developing groundbreaking treatments.
Collaborations
Josef has collaborated with notable professionals in his field, including Eike Staub and Giorgio Massimini. Their combined efforts have further advanced the research and development of innovative cancer therapies.
Conclusion
Josef Straub's contributions to cancer treatment through his patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to pave the way for new therapeutic options for patients in need.